ProPhase Labs, Inc. to Present Third Quarter 2025 Financial Results on November 19
Rhea-AI Summary
Starwood Property Trust (NYSE:STWD) announced a private offering of $500 million aggregate principal amount of unsecured senior notes due 2028. The company said it will allocate net proceeds to finance or refinance eligible green and social projects, and may apply proceeds to repay previously incurred indebtedness tied to those projects. Pending allocation, proceeds may be used for general corporate purposes, including repayment of outstanding indebtedness under the company's repurchase facilities. The Notes will be offered to qualified institutional buyers under Rule 144A and non-U.S. persons under Regulation S, and will not be registered under the Securities Act.
Positive
- $500 million debt raise announced
- Proceeds earmarked for green and social projects
- Proceeds can repay existing indebtedness
Negative
- Notes are unsecured (no asset-backed claim)
- Offering is private (Rule 144A/Reg S) and unregistered
- Pending allocation, proceeds may be used for general corporate purposes
News Market Reaction
On the day this news was published, STWD gained 0.23%, reflecting a mild positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
UNIONDALE, NY, Nov. 18, 2025 (GLOBE NEWSWIRE) -- ProPhase Labs Inc. (NASDAQ: PRPH) (the “Company” or “ProPhase”), a next generation biotech, genomics and consumer products company, announced today that they will be presenting third quarter 2025 financial results on a virtual conference call hosted by Renmark Financial on November 19, 2025, at 2:00 pm EST.
A press release detailing these results will be issued prior to the virtual conference call. ProPhase Labs Inc. welcomes stakeholders, investors and other individual followers to register and attend this live event.
Investors interested in participating in this live event will need to register using the link below. After the event, a replay will be available on The Company’s Investor website.
REGISTER HERE: https://www.renmarkfinancial.com/live-registration/third-quarter-2025-results-virtual-conference-call-nasdaq-prph-xgoCHA0tHl
- To ensure smooth connectivity, please access this link using the latest version of Google Chrome.
About ProPhase Labs Inc.
ProPhase Labs Inc. (Nasdaq: PRPH) (“ProPhase”) is a next-generation biotech, genomics and consumer products company. Our mission is to build a healthier world through bold innovation and actionable insight. We’re revolutionizing healthcare with industry-leading Whole Genome Sequencing solutions, groundbreaking diagnostic development, such as our potentially life-saving test for the early detection of esophageal cancer, and a world class direct-to-consumer marketing platform for cutting edge OTC dietary supplements. We develop, manufacture, and commercialize health and wellness solutions to enable people to live their best lives. We are committed to executional excellence, smart diversification, and a synergistic, omni-channel approach. ProPhase Labs’ valuable subsidiaries, their synergies, and significant growth underscore our potential for long-term value. www.ProPhaseLabs.com
Media Relations Contact:
ProPhase Labs, Inc.
investorrelations@prophaselabs.com
Investor Relations Contact:
Dave Gentry, CEO
RedChip Companies, Inc.
1-800-REDCHIP (733-2447)
1-407-644-4256
PRPH@redchip.com
Retail Investor Relations Contact:
Renmark Financial Communications
John Boidman: jboidman@renmarkfinancial.com
Tel.: (416) 644-2020 or (212) 812-7680
www.renmarkfinancial.com
FAQ
What is Starwood Property Trust announcing with the $500 million note offering (STWD)?
How will Starwood (STWD) use the net proceeds from the $500M 2028 notes?
Who can buy the STWD 2028 notes and are they registered?
What does it mean that the STWD notes are unsecured?
Could proceeds from the STWD offering reduce outstanding repurchase facility debt?
